Radiologia Brasileira - Publicação Científica Oficial do Colégio Brasileiro de Radiologia

INTRODUCTION

Extranodal involvement occurs in 40% of patients with lymphoma⁽¹⁾, representing lymphoproliferative disease in various tissues of the lymph nodes, thymus, and tonsils. The exception is the spleen, where it is classified as extranodal in non-Hodgkin lymphoma (NHL) and nodal in Hodgkin lymphoma⁽²⁾. Lymphomas are classified as primary extranodal when there is no nodal involvement or when there is minimal lymph node involvement and the extranodal component is dominant^(2,3). Secondary involvement, such as advanced disease, is significantly more common^(1,4). The extranodal form is more common in NHL, occurring in 25% of cases. On computed tomography (CT), a lymphoma usually presents with slightly less density than does the parenchyma of the organ involved⁽²⁾. It often shows little contrast uptake⁽²⁾. Heterogeneous enhancement can be seen in large masses, due to areas of central necrosis. Unless previously treated, lymphomas do not typically present calcifications⁽²⁾.


SPLEEN

Splenic involvement occurs in 30–40% of patients with lymphoma⁽⁵⁾. Primary splenic lymphoma is rare. Diffuse infiltration is the most common form of presentation, often resulting in homogeneous splenomegaly, although the spleen can also be of normal size. In such cases, functional imaging methods, such as FDG-PET/CT, facilitate the diagnosis⁽¹⁾. Solitary masses and multifocal lymphomatous nodules are hypointense on CT, with little contrast uptake (Figure 1). One should distinguish them from splenic infarcts, as well as from fungal microabscesses.




LIVER

Primary hepatic lymphoma is rare⁽²⁾. Diffuse infiltration is the most common pattern and can be easily overlooked because of its homogeneous aspect⁽⁵⁾. The nodular pattern is seen in only 10% of cases. Lymphomatous multifocal masses and miliary lesions are similar to metastatic disease and microabscesses. The differentiation is based on the relatively homogeneous aspect of the lymphoma (Figure 2), and magnetic resonance imaging can help. There can be periportal lymphomatous infiltration extending from the porta hepatis.




GALLBLADDER

Primary lymphoma of the gallbladder is very rare. It manifests as focal or diffuse parietal thickening (Figure 3). When occurring in isolation, lymphoma of the gallbladder can be difficult to differentiate from inflammatory cholecystic disease.




PANCREAS

The pancreas is affected in approximately 30% of cases of NHL, usually because it is contiguous to the lymph node involvement^(1,2). There are two distinct morphological patterns: a circumscribed focal mass (Figure 4); and diffuse enlargement due to infiltration. It can resemble acute pancreatitis, because of a diffuse decrease in contrast⁽⁵⁾. There is typically no ductal dilatation or significant parenchymal atrophy, even when there is invasion of the pancreatic duct, which supports the hypothesis of lymphoma instead of adenocarcinoma, the main differential diagnosis⁽⁵⁾. When it affects the cranial and intrapancreatic portions of the common bile duct, it can cause bile duct dilatation (Figure 5).




Other findings that favor the diagnosis of lymphoma are homogeneous density of the lesion and of the highlighting, together with the absence of vascular invasion and of calcifications, as well as the involvement of mesenteric and retroperitoneal lymph nodes.


STOMACH

The gastrointestinal tract (GIT) is the most common abdominal site of primary extranodal lymphoma, the stomach being the segment most often affected⁽⁴⁾. It is known that Helicobacter pylori plays a role in the etiopathogenesis of B-cell mucosa-associated lymphoid tissue type lymphoma, which accounts for 50–70% of primary gastric lymphomas. The most common imaging findings are focal thickening of the gastric wall (Figure 6), usually to a thickness greater than 3 cm, or circumferential parietal involvement (Figure 7). Primary gastric lymphoma can also manifest as a polypoid growth. A reduction in the size of the lumen of the gastric chamber is uncommon, as is upper gastrointestinal bleeding. Although lymphoma and adenocarcinoma can both be accompanied by lymphadenopathy, lymph node enlargement is more extensive in lymphoma.




SMALL INTESTINE

The small intestine is the second most common GIT site affected by lymphoma, the distal ileum being the segment most often affected. Primary lymphoma accounts for over 50% of cases. Lymphoma of the small intestine can present as a polypoid mass, multiple nodules, or (asymmetric or concentric) thickening of the intestinal wall. It typically promotes aneurysmal dilation of the intestinal loop (Figure 8). The primary differential diagnoses are adenocarcinoma, Crohn's disease, and other inflammatory processes.




One important clinical condition that can occur in the context of GIT lymphoma is perforation as the tumor recedes during chemotherapy, which is mainly associated with lymphomas that invade the intestinal wall and respond well to chemotherapy (Figure 9).




COLON

The colon is the third place most common site affected by GIT lymphoma. The cecum and rectum are the sites most often involved⁽¹⁾. Lymphoma of the colon can manifest as a bulky polypoid growth, which is the most common pattern and can cause invaginations. In contrast-enhanced imaging studies, it can also present as an infiltrative mass, thickening of the haustra (Figure 10), and mucosal nodularity. As opposed to colorectal adenocarcinoma, which is the main differential diagnosis, lymphoma affects long segments and, although it can narrow the lumen, rarely creates an obstruction⁽¹⁾.




ADRENAL GLANDS

The adrenal glands are involved in about 4% of all cases of NHL^(1,5), bilaterally in 50% of those cases. The morphological patterns include well-defined homogeneous masses (Figure 11), small nodules, and a diffuse increase in the size of the glands. Non-lymphomatous bilateral adrenal hyperplasia can coexist with lymphoma and must be differentiated from neoplastic involvement, mainly by FDG-PET/CT⁽⁵⁾.




KIDNEYS

In advanced cases of nodal lymphoma, renal involvement is relatively common. Primary renal lymphoma is extremely rare. In 60% of cases, it manifests as multiple, bilateral, homogeneous nodules, with discrete and sometimes progressive impregnation⁽²⁾ (Figure 12). Diffuse lymphomatous infiltration occurs in 20% of cases, preserves the shape of the kidney, and is typically bilateral (Figure 13). Renal masses occur in 10–20% of cases⁽²⁾, can mimic papillary renal cell carcinoma due to the pattern of homogeneous hypovascular impregnation (Figure 14). Contiguous renal invasion in retroperitoneal disease is common and typically manifests as a bulky mass that envelopes but does not obstruct the renal vessels. It usually invades the hilum and displaces the affected kidney (Figure 15). Perirenal involvement that is not secondary to retroperitoneal disease is uncommon. It manifests as homogeneous tissue with density of the soft parts encompassing the renal parenchyma, without causing a significant loss of function (Figure 16). In milder cases, the findings can be limited to thickening of the renal fascia or nodules in the perirenal space. The differential diagnoses include sarcoma of the renal capsule and metastases, as well as benign conditions such as perirenal hematoma, retroperitoneal fibrosis, amyloidosis, and extramedullary hematopoiesis.




PERITONEUM AND MESENTERY

Lymphoma is the most common cause of masses and nodules in the mesenteric lymph nodes, which are most often associated with GIT lymphoma. Such changes are radiologically indistinguishable from those occurring in peritoneal carcinomatosis⁽¹⁾. Increased mesenteric density is most commonly seen after treatment⁽⁵⁾. The patterns of involvement include peritoneal nodules (Figure 17) and a diffuse infiltrative mass. It results in hardening/thickening of the leaflets of the mesentery and an omental cake aspect. Exudative ascites with high attenuation can occur⁽¹⁾.




IMMUNOCOMPROMISED PATIENTS

There is a high incidence of NHL in immunocompromised transplant recipients⁽⁶⁾. It is a serious and relatively common complication, occurring in 2–5% of such patients, and is particularly common after treatment with cyclosporine^(2,5). Its incidence peaks in the first year after transplantation, and it can affect virtually any organ. Isolated lymph node involvement is less common, occurring in only 20% of cases⁽⁷⁾.


CONCLUSION

Extranodal lymphoma can simulate other neoplasms or inflammatory conditions. The radiologist plays a crucial role in the noninvasive management of the disease. In addition to raising suspicion of the diagnosis, the role of the radiologist includes obtaining material via percutaneous biopsy, facilitating the staging, assessing the response to or complications of treatment, and identifying recurrence or relapse.


REFERENCES

1. Lee WK, Lau EWF, Duddalwar VA, et al. Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings. AJR Am J Roentgenol. 2008;191:198–206.

2. Leite NP, Kased N, Hanna RF, et al. Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. Radiographics. 2007;27:1613–34.

3. Silva Neto MM, Jalil EM, Araujo IBO. Extranodal non-Hodgkins lymphomas in Salvador, Brazil: clinical aspects and histopathological classification according to the WHO-2001 guidelines. Rev Bras Hematol Hemoter. 2008;30:36–40.

4. Kwee TC, Nievelstein RAJ, Torigian DA. Role of structural imaging in lymphoma. PET Clin. 2012;7:1–19.

5. Anis M, Irshad A. Imaging of abdominal lymphoma. Radiol Clin North Am. 2008;46:265–85.

6. Borhani AA, Hosseinzadeh K, Almusa O, et al. Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation. Radiographics. 2009;29:981–1002.

7. Camacho JC, Moreno CC, Harri PA, et al. Posttransplantation lymphoproliferative disease: proposed imaging classification. Radiographics. 2014;34:2025–38.










1. Physician in the Program for Continuing Education in Radiology and Diagnostic Imaging at the Centro Radiológico Campinas/Hospital Vera Cruz, Campinas, SP, Brazil
2. Physician in the Program for Continuing Education in Radiology and Diagnostic Imaging at the Hospital e Maternidade Celso Pierro – Pontifícia Universidade Católica de Campinas (PUC Campinas), Campinas, SP, Brazil
3. Full Member of the Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR); MD, Radiologist at the Centro Radiológico Campinas/Hospital Vera Cruz, at the Hospital e Maternidade Celso Pierro – Pontifícia Universidade Católica de Campinas (PUC Campinas), and at the Hospital de Clínicas da Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil
4. Full Member of the Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR); MD, Radiologist at the Centro Radiológico Campinas/Hospital Vera Cruz and at the Hospital e Maternidade Celso Pierro – Pontifícia Universidade Católica de Campinas (PUC Campinas), Campinas, SP, Brazil
5. Full Member of the Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR); MD, Radiologist and Head of the Department of Radiology and Diagnostic Imaging at the Centro Radiológico Campinas/Hospital Vera Cruz, Campinas, SP, Brazil

Mailing address:
Dra. Laís Fajardo
Centro Radiológico Campinas/Hospital Vera Cruz
Avenida Andrade Neves, 402, Centro
Campinas, SP, Brazil, 13013-161
E-mail: laisfajardo@gmail.com

Received October 19, 2015.
Accepted after revision January 31, 2016.

Study conducted at the Centro Radiológico Campinas/Hospital Vera Cruz, Campinas, SP, Brazil.